PAVmed Inc. operates as a medical device company in the United States. The company’s product pipeline includes NextFlo, a disposable infusion pump; PortIO, a long-term implantable vascular access device; Caldus, a disposable tissue ablation device; CarpX, a percutaneous device to treat carpal tunnel syndrome; and NextCath, a self-anchoring short-term catheter. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is headquartered in New York, New York.
Queens, US
2 (est)

Market Position – Health, medical devices

PAVmed Locations

Queens, US

PAVmed Metrics

PAVmed Summary

Founding Date


Market capitalization

$158 M

Closing share price


PAVmed Market Value History

PAVmed News

PAVmed Company Life